"Ozempic Face has emerged as a buzzword in the realm of weight loss medications, coinciding with the rise of the weight loss ...

Researchers analyzed trends in 2023 drug spending to identify factors associated with expenditure growth and to project 2024 drug spending.

About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy, according to a KFF analysis ...

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity ...

As the treatment of obesity in the 21st century takes a monumental turn, the need for quality care is more pressing than ever: Tips for starting a new obesity-focused practice.

The Thousand Oaks, Calif.-based company reported first-quarter results on Thursday, including an update on its weight loss drug in development, which led analysts to update their Amgen stock price ...

Key Takeaways The S&P 500 jumped 1.3% on Friday, May 3, 2024, as the latest jobs report showed a cooling labor market, ...

Citi Analyst Andrew Baum M.D. says the weight loss market could reach double the current projections of $160 billion in peak ...

A review in Current Research in Food Science explores how bioactive compounds in coffee, tea, and cocoa combat obesity by ...

About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 ...